EFFICACY OF ALFUZOSIN VERSUS CONTROL GROUP IN UPPER URETERIC STONE EXPULSION IN ADULT POPULATION OF LAHORE, PAKISTAN

Fawad Humayun; Ghulam Mujtaba; Muhammad Seerwan; Ghazi Khan; Naseem Javed; Muhammad Adnan

doi:10.46903/gjms/19.04.904

EFFICACY OF ALFUZOSIN VERSUS CONTROL GROUP IN UPPER URETERIC STONE EXPULSION IN ADULT POPULATION OF LAHORE, PAKISTAN

Fawad Humayun, Ghulam Mujtaba, Muhammad Seerwan, Ghazi Khan, Naseem Javed, Muhammad Adnan

Abstract

Background: Urinary stone disease is one of the commonest urological diseases worldwide. The objective of this study was to compare the efficacy of alfuzosin versus control group in upper ureteric stone expulsion in adult population of district Lahore, Pakistan.

Materials & Methods: This trial was conducted in Department of Urology, Sheikh Zayed Hospital, Lahore, Pakistan form January 2017 to June 2017. All adult patients with upper ureteric stone size 5-10 mm were eligible. Those with multiple stones, having fever, severe pain, history of surgery in past two weeks and growth on urine culture or pyuria were excluded. Experimental and control groups each had 30 patients. Experimental group received Tab. alfuzosin 10 mg daily for four weeks and Tab. diclofenac sodium 50 mg SOS for acute pain. The control group received Tab. diclofenac sodium 50 mg SOS for acute pain. We followed all patients for four weeks for expulsion of ureteric stones by X-ray KUB or CT KUB. Sex, age and stone size were matching variables. Stone expulsion (yes, no) was research variable. We compared count of stone expulsion between two groups by using McNemar chi-square test at alpha 0.5 using GraphPad.

Results: Out of 30 patients in experimental group, 23 (76.67%) were men and seven (23.33%) women and out of 30 in control group, 20 (66.67%) were men and 10 (33.33%) women, almost similar in both groups. Mean age in experimental group was 39.45±10.33 years and in control group it was 37.38±8.28 years, almost similar in both groups. Mean stone size was 7.45±1.47 (5-10) mm in the experimental and 7.28±1.68 (5-10) mm in control group, being comparable in both the groups. In experimental group, stone expulsion was achieved in 23 (76.67%) cases and not in seven (23.33%) cases and in control group, it was achieved in 16 (53.33%) cases and not in 14 (46.67%) cases. There was statistically no significant difference in efficacy of alfuzosin versus control group (p=.1213).

Conclusion: Our study showed no difference in efficacy of alfuzosin versus control group for upper ureteric stone expulsion in adult population of district Lahore, Pakistan.

Keywords

Upper Ureteric Stone; Alfuzosin; Experimental Group; Control Group; Adult; Urology; Urological Diseases; Pakistan.

Full Text:

PDF

References

Marangella M, Petrarulo M, Vitale C, Bagnis C, Berutti S, Ramello A, et al. The primary hyperoxalurias. Contrib to Nephrol 2001 Jan 1;136:11-32. https://doi.org/10.1159/000060176

Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. J Urol 1997 Nov;158(5):1915-21. https://doi.org/10.1016/S0022-5347(01)64173-9

Tiselius H-G, Alken P, Buck C, Gallucci M, Knoll T, Sarica K, Türk C. Guidelines on Urolithiasis. Update 2008 Mar [accessed 11 Jan 2021]. Available at: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Urolithiasis-2009.pdf

Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999 Sep;162(3 Part 1):688-91. https://doi.org/10.1097/00005392-199909010-00014

Shafi H, Moazzami B, Pourghasem M, Kasaeian A. An overview of treatment options for urinary stones. Caspian J Int Med 2016;7(1):1.

Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases of America Project. Urologic diseases in America project: Urolithiasis. J Urol 2005 Mar;173(3):848-5. https://doi.org/10.1097/01.ju.0000152082.14384.d7

Healy KA, Ogan K. Nonsurgical management of urolithiasis: an overview of expulsive therapy. J Endourol 2005 Sep 1;19(7):759-67. https://doi.org/10.1089/end.2005.19.759

Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of α-blockers for the treatment of ureteral stones. J Urol 2007 Mar;177(3):983-7. https://doi.org/10.1016/j.juro.2006.10.023

Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. An

DOI: https://doi.org/10.46903/gjms/19.04.904